sec-10 Antibody

What is SEC-10 antibody and what cellular functions does it target?

SEC-10 antibody (also known as anti-EXOC5) is a research tool that targets the SEC10/EXOC5 protein, which functions as a component of the exocyst complex. This complex plays a critical role in the docking of exocytic vesicles with fusion sites on the plasma membrane . The exocyst complex is an evolutionarily conserved octameric protein complex essential for tethering secretory vesicles to the plasma membrane prior to SNARE-mediated fusion. SEC10 is known by several names in the research literature, including SEC10L1, EXOC5, Exocyst complex component 5, and hSec10 .

What are the common applications for SEC-10 antibody in research?

SEC-10 antibody is commonly used in several research applications:

• Western Blot (WB): For detecting and quantifying SEC10 protein expression in cell or tissue lysates

• Immunoprecipitation (IP): For isolating and studying SEC10 and its binding partners

• Immunofluorescence (IF): For visualizing the subcellular localization of SEC10 in fixed cells

• Immunohistochemistry (IHC): For examining SEC10 expression in tissue sections

Based on validated testing, commercially available SEC-10 antibodies have been confirmed suitable for immunoprecipitation (IP) and Western blot (WB) applications with human and mouse samples .

What species reactivity has been confirmed for SEC-10 antibodies?

Commercial SEC-10 antibodies, such as the rabbit polyclonal antibody described in the search results, have been validated for reactivity with human and mouse samples . Specifically, this antibody has been tested and confirmed to work with:

• Human cell lines: HeLa (cervical adenocarcinoma), HEK-293T (embryonic kidney), and Jurkat (T cell leukemia)

• Mouse cell lines: TCMK-1 (kidney epithelial) and NIH/3T3 (embryo fibroblast)

When considering using this antibody with other species, researchers should examine sequence homology and consider preliminary validation experiments.

What are the optimal conditions for using SEC-10 antibody in Western blot?

Based on the validated protocols for SEC-10 antibody:

Sample preparation:

• Prepare lysates in NETN lysis buffer for optimal results

• Load approximately 50 μg of whole cell lysate per lane

Antibody conditions:

• Primary antibody concentration: 0.1-1 μg/mL

• Incubation: Overnight at 4°C or 1-2 hours at room temperature

• Detection method: ECL chemiluminescence works well with exposure times of approximately 3 minutes

Expected results:

• Predicted band size: 82 kDa for SEC10/EXOC5

• Clean background with specific bands should be observed in validated cell lines

For troubleshooting, consider the following table of common Western blot issues with SEC-10 antibody:

How should I design an immunoprecipitation experiment using SEC-10 antibody?

For optimal immunoprecipitation with SEC-10 antibody:

Protocol outline:

• Prepare cell lysates in NETN lysis buffer with protease inhibitors

• Use approximately 1 mg of total protein for each IP reaction

• Add 6 μg of SEC-10 antibody per reaction

• Incubate with protein A/G beads

• Wash thoroughly to remove non-specific interactions

• Elute bound proteins and analyze by Western blot

Critical considerations:

• Always include a negative control using non-specific IgG from the same species as the SEC-10 antibody

• For Western blot detection of immunoprecipitated SEC10, use 1 μg/mL of the antibody

• Load approximately 20% of the IP sample for Western blot analysis

• The expected band size for SEC10/EXOC5 is 82 kDa

This approach has been validated for HeLa cells and should work similarly for other human cell lines .

What controls should I include when using SEC-10 antibody in my experiments?

When designing experiments with SEC-10 antibody, the following controls are essential:

For Western blot:

• Positive control: Include lysate from a cell line known to express SEC10 (e.g., HeLa, HEK-293T)

• Negative control: If available, use lysate from SEC10 knockout cells or cells with siRNA-mediated SEC10 knockdown

• Loading control: Include detection of a housekeeping protein (e.g., β-actin, GAPDH)

For immunoprecipitation:

• IgG control: Use non-specific IgG from the same species as the SEC-10 antibody

• Input control: Load 5-10% of pre-IP lysate to confirm protein expression

• Unbound fraction: Analyze flow-through to assess IP efficiency

For immunofluorescence:

• Secondary antibody only control: To assess background fluorescence

• Peptide competition: Pre-incubate antibody with the immunizing peptide to confirm specificity

• siRNA knockdown cells: To validate signal specificity

How can SEC-10 antibody be used to study exocyst complex dynamics?

SEC-10 antibody can be used in several advanced applications to study exocyst complex dynamics:

Co-immunoprecipitation studies:
Perform IP with SEC-10 antibody to isolate the entire exocyst complex and identify interaction partners through mass spectrometry analysis. This approach can reveal:

• Core components of the exocyst complex

• Transient interactions with regulatory proteins

• Post-translational modifications affecting complex assembly

Pulse-chase experiments:
Use SEC-10 antibody in conjunction with metabolic labeling to study:

• Turnover rate of the exocyst complex

• Assembly kinetics under different cellular conditions

• Effects of signaling pathways on complex stability

Proximity ligation assays:
Combine SEC-10 antibody with antibodies against other exocyst components or potential interactors to visualize and quantify protein-protein interactions in situ.

What approaches can be used to validate SEC-10 antibody specificity?

Antibody validation is crucial for ensuring experimental reliability. For SEC-10 antibody, consider these validation approaches:

Genetic validation:

• Test antibody reactivity in SEC10 knockout or knockdown models

• Compare reactivity across multiple cell lines with different SEC10 expression levels

• Use overexpression systems with tagged SEC10 to confirm antibody detection

Analytical validation:

• Peptide competition assays to confirm epitope specificity

• Mass spectrometry analysis of immunoprecipitated proteins

• Multiple antibodies targeting different epitopes of SEC10

Application-specific validation:
When transitioning to a new application (e.g., from WB to IF), perform specific validation experiments for that technique to ensure reliable results.

How can I optimize detection of SEC-10 in challenging sample types or conditions?

For challenging experimental conditions:

Low abundance samples:

• Use enrichment methods (e.g., subcellular fractionation)

• Employ signal amplification techniques (TSA for immunostaining)

• Consider using more sensitive detection systems (Li-COR for Western blot)

Tissues with high background:

• Optimize antigen retrieval methods

• Use alternative blocking agents (e.g., BSA, fish gelatin)

• Consider using monovalent Fab fragments to reduce non-specific binding

Fixed samples:

• Test different fixation methods (paraformaldehyde vs. methanol)

• Optimize permeabilization conditions

• Use epitope retrieval methods if necessary

How should I quantify and normalize SEC-10 expression data from Western blots?

For reliable quantification of SEC-10 expression:

Densitometry approaches:

• Capture images within the linear range of your detection system

• Use software like ImageJ, Image Lab, or specialized densitometry programs

• Measure integrated density values for bands of interest

Normalization strategies:

• Normalize to housekeeping proteins (β-actin, GAPDH, tubulin)

• Consider total protein normalization (Ponceau S, SYPRO Ruby)

• Use loading controls that match your protein of interest in abundance

Statistical considerations:

• Perform experiments with at least three biological replicates

• Apply appropriate statistical tests based on data distribution

• Report both raw and normalized values when possible

What are common sources of variability in SEC-10 antibody experiments?

Understanding sources of variability is essential for troubleshooting and experimental design:

How can I distinguish between different SEC-10 isoforms or post-translational modifications?

To differentiate between SEC-10 variants:

Isoform identification:

• Use high-resolution gel systems (gradient gels, Phos-tag for phosphorylation)

• Compare migration patterns with recombinant isoform standards

• Consider 2D gel electrophoresis to separate isoforms by charge and mass

Post-translational modification analysis:

• Use phosphatase treatment to identify phosphorylated forms

• Apply deglycosylation enzymes to detect glycosylated variants

• Consider using modification-specific antibodies when available

Advanced approaches:

• IP followed by mass spectrometry for detailed PTM mapping

• Use SEC-10 antibodies raised against different epitopes that may be differentially accessible in various protein conformations

What quality control measures ensure consistent SEC-10 antibody performance?

Quality control for antibodies is a critical consideration in research applications:

The developability assessment of antibodies involves evaluating physicochemical properties such as self-interaction, aggregation, thermal stability, and colloidal stability . For research-grade antibodies like SEC-10 antibody, manufacturers typically employ multiple quality control steps:

• Batch-to-batch consistency testing using standardized Western blots

• Species cross-reactivity validation

• Application-specific performance testing

• Stability assessments under various storage conditions

High-throughput developability workflows help in selecting the best antibody candidates based on biological function, efficacy, and physicochemical properties . These workflows typically involve assessing critical developability parameters using small amounts of purified material (<1 mg) .

How do different SEC-10 antibody formats affect experimental design?

Different antibody formats have distinct advantages for specific applications:

Polyclonal antibodies:

• Recognize multiple epitopes, potentially increasing sensitivity

• May have higher background or cross-reactivity

• Batch-to-batch variation can be significant

Monoclonal antibodies:

• Consistent epitope recognition with lower batch variability

• May have lower sensitivity but higher specificity

• Particularly useful for discriminating between closely related proteins

Recombinant antibodies:

• Highly consistent production with minimal batch variation

• Can be engineered for specific applications

• Often available in multiple formats (Fab, scFv, etc.)

When selecting a SEC-10 antibody format, consider the specific requirements of your experimental application and the trade-offs between sensitivity, specificity, and consistency.